- The UTS Centre for Neuroscience and Regenerative Medicine (CNRM) focuses on ground-breaking research and therapies to treat spinal cord injuries, neurological conditions, such as Alzheimer’s and Parkinson’s disease, and mental health conditions.
- UTS is developing state-of-the-art facilities for CNRM’s neurotechnology research with patients at Botany, located with the Faculty of Engineering and IT’s (FEIT) Tech Lab.
- The CNRM facility is an unprecedented opportunity to bring together cutting-edge neuroscience from CNRM with the extraordinary research from FEIT to achieve new neurotechnology solutions for people with spinal cord injury and other conditions such as Parkinson’s disease.
Two years after Professor Bryce Vissel joined UTS to establish and lead a centre for ground-breaking spinal research into spinal cord injury and other devastating conditions, the Centre for Neuroscience and Regenerative Medicine (CNRM) is about to mark a new milestone – the creation of specialist facilities at the university’s new Botany precinct.
Purpose-designed to support the CNRM’s mission to transform the lives of those with spinal cord injury as well as neurodegenerative disorders such as Parkinson’s disease, the purpose-designed 560sqm at Botany will provide:
- research facilities for UTS to undertake cutting edge research on humans with neurological conditions and spinal cord injury
- consultation and state-of-the-art change rooms at the latest accreditation standards, to support clients at optimal levels of care while the research takes place
- latest equipment which will be used to facilitate state-of-the-art neurotechnology research directed to achieve recovery for patients
- staff workspaces and amenities.
Despite the immense progress made by modern medicine, much work remains to be done in unlocking the secrets of the brain and spinal cord, and transforming outcomes for patients and their families. The CNRM is currently working on several projects to restore movement and bodily movement in those with spinal cord injury, as well as research into neurogenesis, the brain’s regeneration and repair drivers.
The research to be undertaken at Botany will be based in the discoveries of Professor Reggie Edgerton, who has been recruited from the University of California, Los Angeles to advance his life changing discoveries for spinal cord injury at UTS. His discoveries are based on new neurotechnology called neuromodulation that, for the first time in history, has allowed patients with spinal cord injury to enable recovery of stepping, hand function, bladder and bowel, temperature, pain and other problems with a magnitude of benefit never before seen.
The bespoke UTS facilities are unique, built in an environment of technology, engineering, big data, 3D printing, new materials and bio-engineering. This will allow CNRM to expand on Professor Edgerton’s discoveries and find vastly improved and different ways to advance treatment of spinal cord injury.
Professor Vissel says that as a result of these discoveries the previously held dogma that recovery after a chronic spinal cord injury is not possible can no longer be held to be true.
“This neurotechnology focused initiative will be a new pillar of Australian neuroscience and medicine,” explains Professor Vissel. “Such a new and unique pillar is critically needed to transform the Australian landscape for patients with neurological conditions, breaking away from traditional biologically based medical research approaches.”
The CNRM also has facilities at St Vincent’s hospital Sydney where it pursues some of its life-changing translational medical research in neuroscience and neurology. The neurotechnology research program aspect of CNRM will locate to the Botany precinct over the next year, with an official launch planned for 2019. This follows the relocation of the Faculty of Engineering and IT’s researchers to the Tech Lab, which commenced in July of this year.
Tech Lab will celebrate its official opening in early September with an event for current and prospective industry partners.